Lung Health, Immunity, and Swallowing
At a Glance
In ataxia-telangiectasia, immune problems, swallowing difficulty, silent aspiration, and a weak cough can work together to damage the lungs. Regular checks of immunity, swallowing, and breathing help the care team find problems early and tailor airway protection and treatment.
In Ataxia-Telangiectasia (A-T), the health of the lungs is closely tied to how the immune system works and how the body manages swallowing [1][2]. Because these systems are so interconnected, doctors take a “multidisciplinary” approach, looking at all three areas to prevent chronic lung damage, which is a leading concern [1][3].
The Immune System in A-T
The ATM gene is essential for developing a diverse and strong immune system [4]. When this gene isn’t working properly, several immune “defects” can occur, though they vary greatly from one person to another [5].
- Antibody Deficiencies: Many patients have low levels of immunoglobulins (antibodies), particularly IgA and certain types of IgG [6][7]. Some may also have a poor response to vaccines, meaning their body doesn’t “remember” how to fight specific germs even after being immunized [8].
- T-cell Issues: The number of T-cells (white blood cells that fight viruses and coordinate the immune response) is often lower than normal, a condition called lymphopenia [9][10].
Managing Immunity: Replacement immunoglobulin (IVIG or SCIG) and daily prophylactic antibiotics are not automatic for everyone. Their use depends on infection burden, quantitative levels, vaccine responses, and specialist judgment [7][6][11]. If an individual has frequent or severe lung infections, donor antibodies may be provided, and prophylactic antibiotics may be carefully considered [12]. Vaccination strategies (especially live vaccines) must also be clinician-directed.
Swallowing and the Risk of “Silent Aspiration”
As A-T progresses, the muscles used for swallowing can become less coordinated, a condition known as oropharyngeal dysphagia [2]. This creates a significant risk for the lungs because of aspiration—when food, liquid, or saliva accidentally enters the airway instead of the stomach [13].
- The Danger of “Silent” Aspiration: In many individuals with A-T, aspiration is “silent,” meaning they do not cough or choke when food goes into their lungs [14]. Over time, this constant irritation can cause chronic inflammation and infections [2].
- Clues to Watch For: Even without a loud choke, signs of swallowing trouble can include a “wet” or gurgly voice after eating, frequent throat clearing, or taking a very long time to finish a meal.
Protecting the Airway: A speech-language pathologist (SLP) should evaluate suspected dysphagia. If a swallowing study is needed, SLPs must weigh the risks of radiation; a Videofluoroscopic Swallow Study (VFSS) uses fluoroscopy, so it should only be ordered when clinically indicated by the swallowing team. Non-ionizing alternatives like FEES may be considered. To manage dysphagia, an SLP may recommend thickened liquids or specialized swallowing techniques [15]. In some cases, a gastrostomy tube (G-tube) may be discussed to provide nutrition. Importantly, a G-tube can support nutrition and hydration but does not prevent aspiration of saliva or refluxed material and does not replace airway-protection planning [16].
Proactive Lung Care (Pulmonary Surveillance)
Because lung damage can happen slowly and quietly, proactive monitoring is the standard of care [3].
- Baseline Evaluations: Doctors usually want a “baseline” look at the lungs when a patient is stable [1]. This might include Spirometry (breathing tests) to measure lung capacity, though these can be difficult for younger children to perform [17].
- Imaging Choices: Because patients with A-T are highly sensitive to radiation, doctors avoid traditional CT scans when a safe alternative is viable [18]. Instead, they may use Lung MRI or ultrasound to monitor for bronchiectasis or interstitial lung disease [19][20]. However, MRI and ultrasound do not provide a general equivalent assessment of aerated lung. A clinically necessary radiograph or low-dose CT should not be delayed merely because of radiosensitivity if the expected benefit outweighs the risk.
- Cough Effectiveness: The same muscle coordination issues that affect walking also affect the ability to cough forcefully [1]. An “ineffective cough” means the patient can’t clear mucus out of their lungs easily [21]. Specialists may recommend “airway clearance” techniques or a mechanical cough-assist machine to help keep the lungs clear during a cold.
By monitoring these three pillars—immunity, swallowing, and lung function—the care team works to identify issues early and intervene before they cause lasting damage [3][2].
Common questions in this guide
Why are lung health, immunity, and swallowing monitored together in A-T?
Does everyone with A-T need IVIG or preventive antibiotics?
What are the warning signs of silent aspiration in ataxia-telangiectasia?
How are swallowing problems evaluated in A-T?
What lung tests are used to monitor ataxia-telangiectasia?
Can a G-tube prevent aspiration in A-T?
When might cough-assist or airway-clearance therapy be recommended?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific tests (like PFTs or non-ionizing imaging) should be repeated and how often to monitor baseline lung health?
- 2.Do the immunoglobulin levels (IgG, IgA, IgM) and vaccine response tests suggest a need for IVIG or SCIG replacement therapy right now?
- 3.Given the risk of silent aspiration, should we schedule a formal swallowing assessment, and what non-ionizing options (like FEES) are considered appropriate?
- 4.What is the plan for monitoring cough effectiveness, and when should we consider using a cough assist machine or airway clearance techniques?
- 5.Are the frequent respiratory symptoms likely due to immune deficiency, aspiration, or a combination of both?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia.
Bhatt JM, Bush A, van Gerven M, et al.
European respiratory review : an official journal of the European Respiratory Society 2015; (24(138)):565-81 doi:10.1183/16000617.0066-2015.
PMID: 26621971 - 2
An overview of proactive monitoring and management of respiratory issues in ataxia-telangiectasia in a specialist and shared care pediatric clinic.
Bhatt JM, Bush A
Frontiers in pediatrics 2024; (12()):1479620 doi:10.3389/fped.2024.1479620.
PMID: 39764161 - 3
Ataxia-telangiectasia: recommendations for multidisciplinary treatment.
van Os NJH, Haaxma CA, van der Flier M, et al.
Developmental medicine and child neurology 2017; (59(7)):680-689 doi:10.1111/dmcn.13424.
PMID: 28318010 - 4
Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity.
Erttmann SF, Härtlova A, Sloniecka M, et al.
Immunity 2016; (45(1)):106-18.
PMID: 27421701 - 5
The clinical significance of complete class switching defect in Ataxia telangiectasia patients.
Ghiasy S, Parvaneh L, Azizi G, et al.
Expert review of clinical immunology 2017; (13(5)):499-505 doi:10.1080/1744666X.2017.1292131.
PMID: 28162005 - 6
Progressive cerebellar ataxia with extensive peripheral telangiectasias in ataxia-telangiectasia.
Ozturk GO, Aksoy YA
BMJ case reports 2025; (18(12)) doi:10.1136/bcr-2025-269367.
PMID: 41469184 - 7
Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives.
McGrath-Morrow SA, Rothblum-Oviatt CC, Wright J, et al.
Journal of multidisciplinary healthcare 2021; (14()):1637-1644 doi:10.2147/JMDH.S295486.
PMID: 34234451 - 8
Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.
Mandola AB, Reid B, Sirror R, et al.
Frontiers in immunology 2019; (10()):2940 doi:10.3389/fimmu.2019.02940.
PMID: 31921190 - 9
Ataxia telangiectasia: a review.
Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al.
Orphanet journal of rare diseases 2016; (11(1)):159 doi:10.1186/s13023-016-0543-7.
PMID: 27884168 - 10
Ataxia-telangiectasia in China: a case report of a novel ATM variant and literature review.
Shao L, Wang H, Xu J, et al.
Frontiers in neurology 2023; (14()):1228810 doi:10.3389/fneur.2023.1228810.
PMID: 37564729 - 11
Rare Genetic Variants Underlying Primary Immunodeficiency: Clinical, Pulmonary, and Genetic Insights from Two Pediatric Cases.
Sikhayeva N, Volodchenko S, Kovzel E, et al.
Genes 2025; (16(11)) doi:10.3390/genes16111247.
PMID: 41300699 - 12
A 10-Year-Old Boy With Ataxia-Telangiectasia: A Rare Case Report From Yemen.
Muneer M, Al-Kubati A, Al-Ghashm A, et al.
Clinical medicine insights. Case reports 2025; (18()):11795476251408138 doi:10.1177/11795476251408138.
PMID: 41458312 - 13
Ataxia-Telangiectasia and Associated Bronchiectasis: Case Report and Literature Review.
Taraș R, Dima M, Axente M, et al.
Journal of clinical medicine 2026; (15(12)) doi:10.3390/jcm15124524.
PMID: 42355692 - 14
Assessment of impaired coordination between respiration and deglutition in children and young adults with ataxia telangiectasia.
Lefton-Greif MA, Perlman AL, He X, et al.
Developmental medicine and child neurology 2016; (58(10)):1069-75 doi:10.1111/dmcn.13156.
PMID: 27214374 - 15
Ataxia Telangiectasia in Siblings: Oral Motor and Swallowing Characterization.
Rondon-Melo S, de Almeida IJ, Andrade CRF, et al.
The American journal of case reports 2017; (18()):783-789 doi:10.12659/ajcr.903592.
PMID: 28698541 - 16
Long-term nutritional and gastrointestinal aspects in patients with ataxia telangiectasia.
Krauthammer A, Lahad A, Sarouk Y, et al.
Nutrition (Burbank, Los Angeles County, Calif.) 2018; (46()):48-52 doi:10.1016/j.nut.2017.08.008.
PMID: 29290356 - 17
FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia.
Vilozni D, Lavie M, Sarouk I, et al.
Respiratory medicine 2015; (109(7)):890-6.
PMID: 26033643 - 18
Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.
Blanchard-Rohner G, Peirolo A, Coulon L, et al.
Frontiers in immunology 2022; (13()):791522 doi:10.3389/fimmu.2022.791522.
PMID: 35154108 - 19
MRI and Biomarkers in Early Detection of Pulmonary Changes in Ataxia-Telangiectasia.
Grzywa-Czuba R, Dmeńska H, Jurkiewicz E, et al.
Medical science monitor : international medical journal of experimental and clinical research 2025; (31()):e946570 doi:10.12659/MSM.946570.
PMID: 40808230 - 20
Imaging in children with ataxia-telangiectasia-The radiologist's approach.
Jończyk-Potoczna K, Potoczny J, Szczawińska-Popłonyk A
Frontiers in pediatrics 2022; (10()):988645 doi:10.3389/fped.2022.988645.
PMID: 36186632 - 21
Immune competence and respiratory symptoms in patients with ataxia telangiectasia: A prospective follow-up study.
Wölke S, Donath H, Bakhtiar S, et al.
Clinical immunology (Orlando, Fla.) 2020; (217()):108491 doi:10.1016/j.clim.2020.108491.
PMID: 32504779
This page is for informational purposes only and does not constitute medical advice. Your ataxia-telangiectasia care team should individualize immune testing, swallowing evaluation, lung monitoring, and treatment.
Get notified when new evidence is published on Ataxia-telangiectasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.